Essay 44-Leukaemia Definintion,Etiology,Pathogeneis and types

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/19

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

20 Terms

1
New cards

Definition

a group of malignant neoplasms originating from hematopoietic stem cells. It is primarily characterized by:

  • Diffuse replacement of the bone marrow by unregulated, proliferating, immature neoplastic (blast) cells.

  • Disruption of normal hematopoiesis, leading to anemia, thrombocytopenia, and neutropenia.

2
New cards

hemopoietic stem cells

Hemopoietic stem cells are the origin of all blood cells

HSCs —> immature blast cell —> mature specialised cell

3
New cards

how do the malignant neoplasms form?

the HSCs —> immature blast cell that can’t mature (mutation)

  • called leukemic blast cells

stops the process of becoming specialised

  • Also has another mutation, uncontrolled cell division

  • they replicate lots

the HSCs should make more healthy Immature B/Cs

However, not enough space, nutrients and GFs in the bone marrow

  • The uncontrolled ones are taking them all

Bone marrow gets taken over by the leukemic blast cells

  • ⇓ in RBCs, platelets and WBCs

4
New cards

Etiology of leukemia

  • Environmental

  • genetic abnormalities

  • therapy-related

  • genetic predisposition

5
New cards

Environmental and chemical exposures:

Ionising radiation (e.g. atomic bomb survivors, radiation therapy).

  • causes DNA damage in HSCs in the bone marrow

  • RESULTS IN :

    • Double-stranded DNA to breakpoint mutations

      • activates oncogenes

      • or inactivates tumour suppressor genes

      • = malignant transformation

Exposure to benzene, certain drugs, industrial toxins, chemicals, and gases.

6
New cards

Genetic abnormalities:

  • Chromosomal translocations and mutations such as:

    • Philadelphia chromosome (t(9;22)), commonly associated with Chronic Myelogenous Leukaemia (CML).

  • Gene mutations that disrupt normal cell cycle control and differentiation.

7
New cards

Therapy-related leukaemia:

May occur as a secondary malignancy following chemotherapy or radiotherapy, especially in Hodgkin's lymphoma.

8
New cards

Genetic predisposition:

Increased incidence seen in congenital disorders such as:

  • Down syndrome

  • Fanconi anemia

  • Bloom syndrome

9
New cards
10
New cards
11
New cards
12
New cards
13
New cards
14
New cards
15
New cards
16
New cards
17
New cards
18
New cards
19
New cards
20
New cards